Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    Biomarkers of chondrosarcoma

    April 22nd, 2023 Journal of Clinical Pathology J Clin Pathol. 2018 Jul; 71(7): 579–583. Published online 2018 Mar 28. doi: 10.1136/jclinpath-2018-205071 PMCID: PMC6204964 PMID: 29593061 Biomarkers of chondrosarcoma Wonju Jeong1 and Ha-Jeong...

    Read Article

    Update on INBRX Clinical Trials from Inhibrx

    April 11th, 2023The INBRX 109 Clinical Trials will shortly resume recruiting patients for their Phase 2 Clinical Trial treating patients with Conventional Chondrosarcoma with recurrence or metastasis. Listed below is a response from Inhibrx: We have just released...

    Read Article

    Chondrosarcoma Patient Registry at one month

    April 7th, 2023The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, a little over one month ago. The registry currently has 60 participants. We want to encourage everyone in the community to...

    Read Article

    Chondrosarcoma Resistance to Radiation Therapy: Origins and,Potential Therapeutic Solutions

    March 29th, 2023Antoine Gilbert 1, Mihaela Tudor 2,3, Juliette Montanari 1, Kevin Commenchail 1 , Diana Iulia Savu 2 ,Paul Lesueur 4,5,6 and François Chevalier 1,* Simple Summary: This review article aims in describing the origins of chondrosarcoma...

    Read Article

    The First Twerk Walking Out Of The Hospital After Kicking Cancer’s Ass Has To Be The Sweetest

    March 23rd, 2023Some of you may not know who Amber Sarcone is. In Philly, she's a part of the royal family. Her family runs Sarcone's Bakery, makers of some of the most delicious damn bread you'll ever have the pleasure of shoving into your mouth. Her cousin is...

    Read Article

    Revolutionary new bone cancer drug identified

    March 16th, 2023A research team led by Dr Darrell Green, a trustee of the Bone Cancer Research Trust, have identified a new drug that works against all main forms of bone cancer. Researchers at the University of East Anglia discovered that the drug, called...

    Read Article

    Recruitment Efforts Underway for the Chondrosarcoma Patient Registry

    March 15th, 2023The Chondrosarcoma Foundation in partnership with the National Organization for Rare Disorders (NORD®) has launched the Chondrosarcoma Patient Registry. The patient registry creates a platform for patients around the world to strengthen their...

    Read Article

    Join us on Tuesday Night to Address Care to Treat Chondrosarcoma

    March 5th, 2023The Chondrosarcoma Foundation is developing a Patient / Family/ Caregiver Advisory Board in the effort to create a voice for chondrosarcoma patient’s and caretakers to address concerns and advocate for effective treatment and quality care. The...

    Read Article